Hasty Briefsbeta

Bilingual

PD-1 blockade plus tyrosine kinase inhibitor remodels the tumor microenvironment in advanced renal cell carcinoma - PubMed

4 hours ago
  • #tumor microenvironment
  • #immunotherapy resistance
  • #renal cell carcinoma
  • Combination of TKIs and ICIs improves outcomes in advanced renal cell carcinoma, but resistance persists.
  • Single-cell analysis showed non-responders had increased neutrophil infiltration and SAA+ tumor cells.
  • A VEGFA+CEACAM1+ neutrophil subset with immunosuppressive properties was linked to poor response.
  • Blocking the SAA-CEACAM1-TIM-3 axis enhanced therapy efficacy in models.
  • The study identifies new targets to overcome resistance in renal cell carcinoma treatment.